Patent details

Basic Information

Publication number:

EP3103469

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP161791504

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CNS DELIVERY OF THERAPEUTIC AGENTS

French Title of Invention:

ADMINISTRATION D'AGENTS THÉRAPEUTIQUES AU SYSTÈME NERVEUX CENTRAL

German Title of Invention:

ABGABE THERAPEUTISCHER MITTEL IN DAS ZNS

SPC Number:

Dates

Filing date:

25/06/2011

Grant date:

09/12/2020

EP Publication Date:

14/12/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/12/2020

EP B1 Publication Date:

09/12/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

25/06/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/09/2022

 

 

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1, Doshomachi 4-chome Chuo-ku, 541-0045, Osaka-shi, Osaka, Japan (JP)

History of Owners

From:

02/12/2020

To:

16/09/2022

Name:

Shire Human Genetic Therapies, Inc.

Address:

300 Shire Way, Lexington MA 02421, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

16/02/2021

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

WRIGHT, Teresa Leah

Address:

United States (US)

2

Name:

CHARNAS, Lawrence

Address:

United States (US)

3

Name:

MCCAULEY, Thomas

Address:

United States (US)

4

Name:

PAN, Jing

Address:

United States (US)

5

Name:

PFEIFER, Richard

Address:

United States (US)

6

Name:

SHAHROKH, Zahra

Address:

United States (US)

7

Name:

POWELL, Jan

Address:

United States (US)

8

Name:

CALIAS, Pericles

Address:

United States (US)

Priority

1

Priority Number:

358857 P

Priority Date:

25/06/2010

Priority Country:

United States (US)

2

Priority Number:

360786 P

Priority Date:

01/07/2010

Priority Country:

United States (US)

3

Priority Number:

387862 P

Priority Date:

29/09/2010

Priority Country:

United States (US)

4

Priority Number:

201161435710 P

Priority Date:

24/01/2011

Priority Country:

United States (US)

5

Priority Number:

201161442115 P

Priority Date:

11/02/2011

Priority Country:

United States (US)

6

Priority Number:

201161476210 P

Priority Date:

15/04/2011

Priority Country:

United States (US)

7

Priority Number:

201161495268 P

Priority Date:

09/06/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 9/19; A61K 38/46; A61K 38/47; A61P 25/00; A61P 25/28;

Publication

European Patent Bulletin

1

Issue number:

202050

Publication date:

09/12/2020

Description:

Grant (B1)

2

Issue number:

202141

Publication date:

13/10/2021

Description:

Opposition procedure started

3

Issue number:

202102

Publication date:

13/01/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

4

Issue number:

202242

Publication date:

19/10/2022

Description:

Transfer of Rights

Annual Fees

Annual Fee Due Date:

30/06/2025

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

21/05/2024

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
16/02/2021	Power Of Attorney	1
19/02/2021	Outgoing Correspondence	1